↓ Skip to main content

Improvement in the regulation of the vitamin K antagonist acenocoumarol after a standard initial dose regimen: prospective validation of a prescription model

Overview of attention for article published in Journal of Thrombosis and Thrombolysis, February 2008
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
15 Mendeley
Title
Improvement in the regulation of the vitamin K antagonist acenocoumarol after a standard initial dose regimen: prospective validation of a prescription model
Published in
Journal of Thrombosis and Thrombolysis, February 2008
DOI 10.1007/s11239-008-0203-4
Pubmed ID
Authors

Johanna H. H. Van Geest-Daalderop, Barbara A. Hutten, Nathalie C. V. Péquériaux, Marcel Levi, Augueste Sturk

Abstract

In a retrospective study we have developed a model which determines the dose of acenocoumarol based on the age of the patient and on the first INR obtained after a standard initial loading dose. The group of patients of this study was used as the control group of the present study.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 20%
Other 2 13%
Professor 2 13%
Student > Postgraduate 2 13%
Professor > Associate Professor 2 13%
Other 3 20%
Unknown 1 7%
Readers by discipline Count As %
Medicine and Dentistry 6 40%
Nursing and Health Professions 2 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Computer Science 1 7%
Agricultural and Biological Sciences 1 7%
Other 2 13%
Unknown 2 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2020.
All research outputs
#7,453,827
of 22,787,797 outputs
Outputs from Journal of Thrombosis and Thrombolysis
#345
of 965 outputs
Outputs of similar age
#43,321
of 158,148 outputs
Outputs of similar age from Journal of Thrombosis and Thrombolysis
#1
of 5 outputs
Altmetric has tracked 22,787,797 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 965 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,148 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them